Stocktoria
NEUROONE MEDICAL TECHNOLOGIES Corp NMTC
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2012-11-09
NEUROONE MEDICAL TECHNOLOGIES Corp statistics & valuation
Market cap$29.1M
P / S3.2×
P / B4.1×
Net margin-39.6%
Return on equity-51.0%
FCF margin-32.1%
Return on capital-49.8%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 56.5% | 31.3% | 23.4% | -41.4% | -54.9% | — | — | — | — | — |
| Operating margin | -46.5% | -344.3% | -612.3% | -5860.2% | -5735.9% | — | — | — | — | -4646.1% |
| Net margin | -39.6% | -356.7% | -607.4% | -5842.0% | -5584.3% | — | — | — | — | -4688.7% |
| FCF margin | -32.1% | -322.4% | -679.7% | -4553.8% | -4866.7% | — | — | — | — | — |
| Return on assets | -33.4% | -229.4% | -146.5% | -78.0% | -125.3% | -286.6% | -1273.2% | -6.3% | -3420.2% | -17680.0% |
| Return on equity | -51.0% | -1498.5% | -189.8% | -104.1% | -151.8% | -660.2% | 547.9% | 17.9% | 77.1% | 102.4% |
| Current ratio | 4.44 | 2.09 | 4.08 | 3.93 | 6.17 | 1.76 | 0.17 | 0.85 | 0.02 | 0.01 |
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.